Bcl-2 proteins: Regulators of apoptosis or of mitochondrial homeostasis?

Nature Cell Biology

Volumn 1, Issue 8, 1999, Pages E209-E216

  Heiden, Matthew G Vander ^a,b   Thompson, Craig B ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CASPASE; CYTOCHROME C; ION CHANNEL; MEMBRANE PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTEIN BCL 2;

ANIMAL; APOPTOSIS; CHEMISTRY; ENZYMOLOGY; HOMEOSTASIS; HUMAN; METABOLISM; MITOCHONDRION; NECROSIS; PATHOLOGY; REVIEW;

ANIMALS; APOPTOSIS; CASPASES; CYTOCHROME C GROUP; HOMEOSTASIS; HUMANS; ION CHANNELS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NECROSIS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0033258120     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/70237     Document Type: Article

References (101)

1. Newmeyer, D. D., Farschon, D. M. & Reed, J. C. Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79, 353–364 (1994).
2. Liu, X., Kim, C. N., Yang, J., Jemmerson, R. & Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147–157 (1996).
3. Thornberry, N. A. & Lazebnik, Y. Caspases: enemies within. Science 281, 1312–1316 (1998).
4. Zou, H., Henzel, W. J., Liu, X., Lutschg, A. & Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405–413 (1997).
5. Li, P. et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479–489 (1997).
6. Hu, Y., Benedict, M. A., Ding, L. & Nunez, G. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J. 18, 3586–3595 (1999).
7. Saleh, A., Srinivasula, S. M., Acharya, S., Fishel, R. & Alnemri, E. S. Cytochrome c and dATPmediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J. Biol. Chem. 274, 17941–17945 (1999).
8. Zou, H., Li, Y., Liu, X. & Wang, X. An APAF-1•cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274, 11549–11556 (1999).
9. Slee, E. A. et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144, 281–292 (1999).
10. Mayer, A., Neupert, W. & Lill, R. Translocation of apocytochrome c across the outer membrane of mitochondria. J. Biol. Chem. 270, 12390–12397 (1995).
11. Kluck, R. M. et al. Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J. 16, 4639–4649 (1997).
12. Susin, S. A. et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med. 189, 381–394 (1999).
13. Mancini, M. et al. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J. Cell Biol. 140, 1485–1495 (1998).
14. Samali, A., Zhivotovsky, B., Jones, D. P. & Orrenius, S. Detection of pro-caspase-3 in cytosol and mitochondria of various tissues. FEBS Lett. 431, 167–169 (1998).
15. Samali, A., Cai, J., Zhivotovsky, B., Jones, D. P. & Orrenius, S. Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. EMBO J. 18, 2040–2048 (1999).
16. Krajewski, S. et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl Acad. Sci. USA 96, 5752–5757 (1999).
17. Susin, S. A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441–446 (1999).
18. Kluck, R. M., Bossy-Wetzel, E., Green, D. R. & Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132–1136 (1997).
19. Yang, J. et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129–1132 (1997).
20. Vander Heiden, M. G., Chandel, N. S., Williamson, E. K., Schumacker, P. T. & Thompson, C. B. BclxL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91, 627–637 (1997).
21. Bossy-Wetzel, E., Newmeyer, D. D. & Green, D. R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17, 37–49 (1998).
22. Manon, S., Chaudhuri, B. & Guerin, M. Release of cytochrome c and decrease of cytochrome c oxidase in Bax-expressing yeast cells, and prevention of these effects by coexpression of Bcl-xL. FEBS Lett. 415, 29–32 (1997).
23. Rosse, T. et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391, 496–499 (1998).
24. Jurgensmeier, J. M. et al. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl Acad. Sci. USA 95, 4997–5002 (1998).
25. Pastorino, J. G., Chen, S. T., Tafani, M., Snyder, J. W. & Farber, J. L. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem. 273, 7770–7775 (1998).
26. Vander Heiden, M. G., Chandel, N. S., Schumacker, P. T. & Thompson, C. B. Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol. Cell 3, 159–167 (1999).
27. Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L. & Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241–251 (1993).
28. Kane, D. J. et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262, 1274–1277 (1993).
29. Gottlieb, R. A., Nordberg, J., Skowronski, E. & Babior, B. M. Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc. Natl Acad. Sci. USA 93, 654–658 (1996).
30. Zamzami, N. et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367–377 (1995).
31. Shimizu, S. et al. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc. Natl Acad. Sci. USA 95, 1455–1459 (1998).
32. Nguyen, M., Millar, D. G., Yong, V. W., Korsmeyer, S. J. & Shore, G. C. Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J. Biol. Chem. 268, 25265–25268 (1993).
33. Krajewski, S. et al. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53, 4701–4714 (1993).
34. Tanaka, S., Saito, K. & Reed, J. C. Structure-function analysis of the Bcl-2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bcl-2 beta protein restores function as a regulator of cell survival. J. Biol. Chem. 268, 10920–10926 (1993).
35. Nguyen, M. et al. Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. J. Biol. Chem. 269, 16521–16524 (1994).
36. Wolter, K. G. et al. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281–1292 (1997).
37. Hsu, Y. T., Wolter, K. G. & Youle, R. J. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc. Natl Acad. Sci. USA 94, 3668–3672 (1997).
38. Gross, A., Jockel, J., Wei, M. C. & Korsmeyer, S. J. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17, 3878–3885 (1998).
39. Cheng, E. H., Levine, B., Boise, L. H., Thompson, C. B. & Hardwick, J. M. Bax-independent inhibition of apoptosis by Bcl-XL. Nature 379, 554–556 (1996).
40. Minn, A. J. et al. Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms. EMBO J. 18, 632–643 (1999).
41. Chinnaiyan, A. M., O’Rourke, K., Lane, B. R. & Dixit, V. M. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275, 1122–1126 (1997).
42. Spector, M. S., Desnoyers, S., Hoeppner, D. J. & Hengartner, M. O. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature 385, 653–656 (1997).
43. Wu, D., Wallen, H. D. & Nunez, G. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 275, 1126–1129 (1997).
44. Pan, G., O’Rourke, K. & Dixit, V. M. Caspase-9, Bcl-xL, and Apaf-1 form a ternary complex. J. Biol. Chem. 273, 5841 (1998).
45. Hu, Y., Benedict, M. A., Wu, D., Inohara, N. & Nunez, G. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl Acad. Sci. USA 95, 4386–4391 (1998).
46. Moriishi, K., Huang, D. C., Cory, S. & Adams, J. M. Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1. Proc. Natl Acad. Sci. USA 96, 9683–9688 (1999).
47. Chang, B. S., Minn, A. J., Muchmore, S. W., Fesik, S. W. & Thompson, C. B. Identification of a novel regulatory domain in Bcl-xL and Bcl-2. EMBO J. 16, 968–977 (1997).
48. Muchmore, S. W. et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335–341 (1996).
49. Minn, A. J. et al. Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature 385, 353–357 (1997).
50. Schendel, S. L. et al. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl Acad. Sci. USA 94, 5113–5118 (1997).
51. Antonsson, B. et al. Inhibition of Bax channel-forming activity by Bcl-2. Science 277, 370–372 (1997).
52. Schendel, S. L. et al. Ion channel activity of the BH3 only Bcl-2 family member, BID. J. Biol. Chem. 274, 21932–21936 (1999).
53. Matsuyama, S., Schendel, S. L., Xie, Z. & Reed, J. C. Cytoprotection by Bcl-2 requires the poreforming alpha5 and alpha6 helices. J. Biol. Chem. 273, 30995–31001 (1998).
54. Shimizu, S., Narita, M. & Tsujimoto, Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483–487 (1999).
55. Zamzami, N., Brenner, C., Marzo, I., Susin, S. A. & Kroemer, G. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 16, 2265–2282 (1998).
56. Basanez, G. et al. Bax, but not Bcl-xL, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations. Proc. Natl Acad. Sci. USA 96, 5492–5497 (1999).
57. Cosulich, S. C., Worall, V., Hedge, P. J., Green, S. & Clarke, P. R. Regulation of apoptosis by BH3 domains in a cell-free system. Curr. Biol. 7, 913–920 (1997).
58. Pattus, F., Heitz, F., Martinez, C., Provencher, S. W. & Lazdunski, C. Secondary structure of the poreforming colicin A and its C-terminal fragment. Experimental fact and structure prediction. Eur. J. Biochem. 152, 681–689 (1985).
59. Single, B., Leist, M. & Nicotera, P. Simultaneous release of adenylate kinase and cytochrome c in cell death. Cell Death Differ. 5, 1001–1003 (1998).
60. Kohler, C. et al. Release of adenylate kinase 2 from the mitochondrial intermembrane space during apoptosis. FEBS Lett. 447, 10–12 (1999).
61. Priault, M., Chaudhuri, B., Clow, A., Camougrand, N. & Manon, S. Investigation of bax-induced release of cytochrome c from yeast mitochondria: permeability of mitochondrial membranes, role of VDAC and ATP requirement. Eur. J. Biochem. 260, 684–691 (1999).
62. Green, D. & Kroemer, G. The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 8, 267–271 (1998).
63. Zoratti, M. & Szabo, I. The mitochondrial permeability transition. Biochim. Biophys. Acta 1241, 139–176 (1995).
64. Zamzami, N. et al. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183, 1533–1544 (1996).
65. Scorrano, L., Petronilli, V., Di Lisa, F. & Bernardi, P. Commitment to apoptosis by GD3 ganglioside depends on opening of the mitochondrial permeability transition pore. J. Biol. Chem. 274, 22581–22585 (1999).
66. Kristal, B. S. & Brown, A. M. Apoptogenic ganglioside GD3 directly induces the mitochondrial permeability transition. J. Biol. Chem. 274, 23169–23175 (1999).
67. Zamzami, N. et al. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 384, 53–57 (1996).
68. Eskes, R. et al. Bax-induced cytochrome C release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions. J. Cell Biol. 143, 217–224 (1998).
69. Petronilli, V. et al. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J. 76, 725–734 (1999).
70. Minamikawa, T., Williams, D. A., Bowser, D. N. & Nagley, P. Mitochondrial permeability transition and swelling can occur reversibly without inducing cell death in intact human cells. Exp. Cell Res. 246, 26–37 (1999).
71. Kerr, P. M., Suleiman, M. S. & Halestrap, A. P. Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate. Am. J. Physiol. 276, H496–H502 (1999).
72. Ichas, F. & Mazat, J. P. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim. Biophys. Acta 1366, 33–50 (1998).
73. Bradham, C. A. et al. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol. Cell. Biol. 18, 6353–6364 (1998).
74. Crompton, M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341, 233–249 (1999).
75. Brdiczka, D., Beutner, G., Ruck, A., Dolder, M. & Wallimann, T. The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition. Biofactors 8, 235–242 (1998).
76. Wyss, M., Smeitink, J., Wevers, R. A. & Wallimann, T. Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochim. Biophys. Acta 1102, 119–166 (1992).
77. Adams, V. et al. Porin interaction with hexokinase and glycerol kinase: metabolic microcompartmentation at the outer mitochondrial membrane. Biochem. Med. Metab. Biol. 45, 271–291 (1991).
78. Marzo, I. et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281, 2027–2031 (1998).
79. Marzo, I. et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J. Exp. Med. 187, 1261–1271 (1998).
80. Narita, M. et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl Acad. Sci. USA 95, 14681–14686 (1998).
81. Hackenbrock, C. R. Ultrastructural bases for metabolically linked mechanical activity in mitochondria. I. Reversible ultrastructural changes with change in metabolic steady state in isolated liver mitochondria. J. Cell Biol. 30, 269–297 (1966).
82. Banki, K., Hutter, E., Gonchoroff, N. J. & Perl, A. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J. Immunol. 162, 1466–1479 (1999).
83. Kennedy, S. G., Kandel, E. S., Cross, T. K. & Hay, N. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell. Biol. 19, 5800–5810 (1999).
84. Bernardi, P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 79, 1127–1155 (1999).
85. Halestrap, A. P. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim. Biophys. Acta 973, 355–382 (1989).
86. Rostovtseva, T. & Colombini, M. VDAC channels mediate and gate the flow of ATP: implications for the regulation of mitochondrial function. Biophys. J. 72, 1954–1962 (1997).
87. Hodge, T. & Colombini, M. Regulation of metabolite flux through voltage-gating of VDAC channels. J. Membr. Biol. 157, 271–279 (1997).
88. Vaux, D. L., Cory, S. & Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440–442 (1988).
89. Decker, R. S. & Wildenthal, K. Lysosomal alterations in hypoxic and reoxygenated hearts. I. Ultrastructural and cytochemical changes. Am. J. Pathol. 98, 425–444 (1980).
90. Shimizu, S. et al. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13, 21–29 (1996).
91. McCarthy, N. J., Whyte, M. K., Gilbert, C. S. & Evan, G. I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136, 215–227 (1997).
92. Amarante-Mendes, G. P. et al. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death. Cell Death Differ. 5, 298–306 (1998).
93. Soengas, M. S. et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284, 156–159 (1999).
94. Deshmukh, M. & Johnson, E. M. Jr Evidence of a novel event during neuronal death: development of competence-to-die in response to cytoplasmic cytochrome c. Neuron 21, 695–705 (1998).
95. Martinou, I. et al. The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event. J. Cell Biol. 144, 883–889 (1999).
96. Deveraux, Q. L. et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17, 2215–2223 (1998).
97. Tang, D. G., Chen, Y. Q. & Honn, K. V. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc. Natl Acad. Sci. USA 93, 5241–5246 (1996).
98. van Leyen, K., Duvoisin, R. M., Engelhardt, H. & Wiedmann, M. A function for lipoxygenase in programmed organelle degradation. Nature 395, 392–395 (1998).
99. Eguchi, Y., Shimizu, S. & Tsujimoto, Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57, 1835–1840 (1997).
100. Leist, M., Single, B., Castoldi, A. F., Kuhnle, S. & Nicotera, P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185, 1481–1486 (1997).
101. Zhu, W. et al. Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J. 15, 4130–4141 (1996).